ARTA
ATYR

A.R.T. Advisors’s aTyr Pharma ATYR Stock Holding History

A.R.T. Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,094
Closed -$35K – 1710
2018
Q3 		$35K Buy
3,094
+730
+31% +$7.99K ﹤0.01% 1331
2018
Q2 		$30K Buy
+2,364
New +$56.1K ﹤0.01% 1352
2017
Q1 		– Sell
-977
Closed -$29K – 1757
2016
Q4 		$29K Buy
+977
New +$40.1K ﹤0.01% 1233
2016
Q3 		– Sell
-2,796
Closed -$108K – 1204
2016
Q2 		$108K Buy
2,796
+1,315
+89% +$61.1K 0.01% 1195
2016
Q1 		$81K Buy
+1,481
New +$113K ﹤0.01% 1269

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

A.R.T. Advisors's ATYR Position: Q4 2018 in Review

A.R.T. Advisors sold out of aTyr Pharma (ATYR) in Q4 2018, closing a stake of 3,094 shares — an estimated $35K sold.

A.R.T. Advisors first reported a position in ATYR in Q1 2016 and held it in 5 quarters. The position peaked at $108K in Q2 2016. 29 funds tracked by Wall St. Rank hold ATYR as of Q4 2018.

  • A.R.T. Advisors reported no remaining aTyr Pharma position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 3,094 aTyr Pharma shares in Q4 2018, an estimated $35K.
  • A.R.T. Advisors first reported a position in aTyr Pharma in Q1 2016 and held it in 5 quarters.
  • A.R.T. Advisors's aTyr Pharma position peaked at $108K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.